Unilever stays competitive against a tough backdrop - here's why

Unilever delivered competitive Q2 organic sales growth of 3.8% and exceeded margin expectations, leading Barclays to raise its full-year margin forecast to 18.9%. Barclays anticipates accelerated organic sales growth into H2, projecting 4.6% in Q4, fueled by Asian recovery and sustained developed market momentum. This positive outlook, supported by ongoing innovation, strategic acquisitions, and the planned Magnum spin-off, underpins Barclays' continued 'overweight' rating and slightly increased price target.

Analysis

Unilever PLC demonstrated resilience in a challenging consumer environment, delivering a competitive 3.8% organic sales growth (OSG) in the second quarter, which beat on margins. This performance led Barclays to upgrade its full-year margin forecast to 18.9%, a crucial factor expected to drive growth in hard currency earnings. The outlook appears positive, with Barclays forecasting an acceleration in OSG to 4.1% in Q3 and 4.6% in Q4, fueled by a recovery in key Asian markets—including an acceleration in India and recovery in China—and sustained momentum in developed regions. While Latin America has been soft, a turnaround is anticipated. The positive sentiment is further supported by management's upbeat tone and strategic initiatives, including ongoing innovation, premiumisation, and bolt-on acquisitions in the Beauty and Wellbeing sectors. The upcoming spin-off of the Magnum Ice Cream business is also highlighted as a significant potential catalyst for unlocking shareholder value, underpinning Barclays' decision to maintain its 'overweight' rating and increase its price target to £54.00.

Key Decisions for Investors

• Given the combination of expanding margins, accelerating sales growth forecasts, and positive management guidance, investors may view the current situation as supportive of a bullish position on the stock.
• Monitor key upcoming catalysts for thesis validation, specifically the execution of the Magnum Ice Cream spin-off and evidence of the projected sales recovery in Asia and Latin America in the second half of the year.
• The company's strategic focus on premiumisation and targeted acquisitions in high-growth segments like Beauty and Wellbeing should be considered a core driver of potential long-term value creation.